Diagnostic And Consulting Center 1 Veliko Tarnovo Ltd.
- Address
- Ulitsa Marno Pole 21, 5000 Veliko Tirnovo, Bulgaria
Diagnostic And Consulting Center 1 Veliko Tarnovo Ltd.
Diagnostic And Consulting Center 1 Veliko Tarnovo Ltd. is a clinical research facility specializing in cardiovascular and metabolic disease studies. The center has developed particular expertise in conducting Phase 3 trials evaluating novel therapeutic approaches for hypertension and lipid disorders, contributing to the advancement of preventive cardiology and cardiovascular risk management.
- Lipid-lowering therapies and hypercholesterolemia management, including innovative PCSK9 inhibitor studies
- Uncontrolled and resistant hypertension treatment with novel antihypertensive agents
- Primary prevention of atherosclerotic cardiovascular disease (ASCVD) and major adverse cardiovascular events
The center's research portfolio demonstrates a comprehensive approach to cardiovascular disease prevention and treatment, ranging from cholesterol management to complex resistant hypertension cases. Their involvement in long-term extension studies and randomized withdrawal trials showcases their capability to assess both immediate efficacy and sustained safety profiles of investigational medications. This expertise positions them as a valuable contributor to understanding how emerging therapies can reduce cardiovascular risk and improve patient outcomes in both primary and secondary prevention settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diagnostic And Consulting Center 1 Veliko Tarnovo Ltd.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Inclisiran in Reducing Major Adverse Cardiovascular Events in High-Risk Primary Prevention of Atherosclerotic Cardiovascular Disease | Novartis Pharma AG | Phase III | Not Recruiting | Sep 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 3 | Unknown | 2022-04-08 | 2023-09-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.